About Genomic Prediction
Genomic Prediction is a company based in North Brunswick (United States) founded in 2017. It operates as a B2B. Genomic Prediction has raised $4.5 million across 1 funding round from investors including Nimble Ventures and PeopleFund. Genomic Prediction operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Auxogyn, Overture Life and Clinical Microbiomics, among others.
- Headquarter North Brunswick, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.5 M (USD)
in 1 rounds
-
Latest Funding Round
$4.5 M (USD), Series A
Jan 31, 2019
-
Investors
Nimble Ventures
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Genomic Prediction
Genomic Prediction has successfully raised a total of $4.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.5 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $4.5M
-
First Round
First Round
(31 Jan 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Series A - Genomic Prediction | Valuation | Nimble Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genomic Prediction
Genomic Prediction has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Nimble Ventures and PeopleFund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by Nimble Ventures.
|
Founded Year | Domain | Location | |
|
Seed to growth stage tech-focused VC and PE firm investing in geographies such as the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genomic Prediction
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genomic Prediction
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genomic Prediction Comparisons
Competitors of Genomic Prediction
Genomic Prediction operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Auxogyn, Overture Life and Clinical Microbiomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for IVF embryo viability assessment are developed.
|
|
| domain | founded_year | HQ Location |
Embryology diagnosis devices are developed for medical professionals.
|
|
| domain | founded_year | HQ Location |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| domain | founded_year | HQ Location |
BGI is engaged in genomics and precision medicine solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genomic Prediction
Frequently Asked Questions about Genomic Prediction
When was Genomic Prediction founded?
Genomic Prediction was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Genomic Prediction located?
Genomic Prediction is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
Is Genomic Prediction a funded company?
Genomic Prediction is a funded company, having raised a total of $4.5M across 1 funding round to date. The company's 1st funding round was a Series A of $4.5M, raised on Jan 31, 2019.
What does Genomic Prediction do?
Genomic Prediction operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and ivf testing. Offers genomics tests to predict health outcomes for IVF procedures. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Who are the top competitors of Genomic Prediction?
Genomic Prediction's top competitors include Novogene Corporation, BGI and Overture Life.
Who are Genomic Prediction's investors?
Genomic Prediction has 2 investors. Key investors include Nimble Ventures, and PeopleFund.